Top

Reactions Weekly

Published in:

01-12-2023 | Osimertinib | Case report

Multiple drugs

Drug intolerence and lack of efficacy

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Zhang X, et al. EP12.01-15 Aumolertinib Combination SBRT Treated EGFR Co-mutation Patients with Symptomatic Brain Metastases: A Case Report. Journal of Thoracic Oncology 18 (Suppl. ): S646 abstr. EP12.01-15, No. 11, Nov 2023. Available from: URL: https://dx.doi.org/10.1016/j.jtho.2023.09.1230 [abstract]

Title: Multiple drugs
Drug intolerence and lack of efficacy
Publication date: 01-12-2023
Publisher: Springer International Publishing
Keywords: Osimertinib
Lung Cancer
Lung Cancer
Lung Cancer
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-51108-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Multiple drugs

Drug intolerence and lack of efficacy

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Azathioprine/Hydroxychloroquine/Prednisone

Multiple drugs

Hydroxychloroquine/ACE inhibitors/immunosuppressants

Clopidogrel

Larotrectinib

Naxitamab